|
|

| General
Information |

Common Name: |

Valerian |
|
Latin
Name:
|
Valeriana
officinalis |
|
Family:
|
Valerianaceae |
| Other
Names: |
 |
All
heal.
|
 |
Belgian
valerian.
|
 |
Fragrant
valerian.
|
 |
Indian
valerian.
|
 |
Garden
heliotrope.
|
|
| Indications
& Historical Uses |
|
Valerian
in the form of dried rhizome [underground stems ] and root of
the Valerian officinalis plant, has been used for over 1,000 years
as a valued calmative agent, tranquillizer and hypnotic.
The
German Commission E has indicated that Valerian is an effective
treatment for restlessness and for sleep disturbances resulting
from nervous conditions. It is used extensively and effectively
in Europe, and in France and it is the most widely used and prescribed
hypnotic
Its
general indications are as follows:
 |
Insomnia (Sleeplessness).
|
 |
Nervous
tension, anxiety.
|
 |
Headache.
|
 |
Palpitations
without any cause.
|
 |
Irritable
bowel syndrome.
|
 |
Menstrual
cramps.
|
 |
Mild
cases of attention deficit disorder (ADD).
|
It
is very important to note that valerian does not cause any hangover
effects after use.
|
| Contraindications
& Precautions |
|
Contraindications:
No known toxicity High doses (5 gms per day) may lead to withdrawal
symptoms if taken for a long period of time. Avoid prolonged use
and large doses. See
Caution.
Precautions:
No known toxicity High doses (5 mgs per day) may lead to withdrawal
symptoms if taken for a long period of time. Avoid prolonged use
and large doses.
Adverse
Effects:
No known toxicity High doses (5mg per day) may lead to withdrawal
symptoms if taken for a long period of time. Avoid prolonged use
and large doses. See
Caution.
Drug
Interaction:
See
Caution.
No
drug interactions known, however, people who use Valerian might
be wise to avoid taking any hypnotic or sedative agents e.g. benzodiazepines.
|
| Dosage
Information |
|
How
Supplied:
|
200mg
and 500mg tablets. |
|
Dosage:
|
200mg
- 500mg per day. |
| Pharmacology
|
|
The
sedative effects of Valerian root are attributed to the Valpotriates,
which are a group of unstable compounds whose byproducts also
possess sedative activity. Other components, such as the pungent
Valeric and Isovaleric acids also have CNS depressant activity.
Numerous
clinical trials with Valerian have established both subjective
and objective improvements in sleep quality, tension disturbances
and behavior disorders without causing a hangover effect the next
day.
Valerian
has been studied for its effects on the inhibitory neurotransmitter
GABA (gamma-aminobutyric acid) which is the same neurotransmitter
affected by barbituates and benzodiazepines. Animal research has
shown that extracts of valerian root does in fact increase the
levels of GABA in the synapse .. It is postulated that Valerian
exerts its effect by increasing a carrier protein-dependent re-uptake
of the neurotransmitter, hence, Valerian root may be considered
a re-uptake inhibitor of GABA somewhat similar to serotonin re-uptake
inhibition by the SSRI's .
|
|
Active
Ingredients:
|
 |
Valpotriates.
|
 |
Valeric
acid.
|
 |
Sesquiterpenes.
|
 |
Glycoside.
|
 |
Essential
oils.
|
|
|
Enhancing
Agents:
|
 |
Passion flower.
|
 |
Hops hawthorn.
|
 |
Phosphotidylserin.
|
|
| Origin |
|
Valerian
Officinalis is a tall perennial that grows in temperate regions
of North America, Europe ,and Asia.. Clusters of tiny white or
reddish flowers bloom in summer. The herb emits an unpleasant
odor as it dries .There are over 200 valeriana species but V.
officinalis is the species most frequently cultivated for medicinal
use.
Since
ancient Greek times ,valerian has been valued as an antispasmodic
and as a sleep aid. Today ,valerian is widely used throughout
Europe as a mild sedative and as a sleep aid for insomnia .
|
| Processing |
|
Valerian
roots are collected in spring and fall and dried. This dried product
is then cold percolated with alcohol and water, and evaporated
at cool temperature. It is then purified and standardized.
|
| Scientific
References |
 |
Chauffard, F. et al. (1982) Detection of mild sedative effects:
Valerian and sleep in man. Experimentia 37:622.
|
 |
Delsignore, R. et al. (1980) Placebo controlled clinical
trial with valerian. Settimana Medica 68(8):437.
|
 |
Drieglsten, J. and Grusla, D. (1988) Central depressant
constituent in Valerian. Deutsche Apotheker Zeitung.
40:204l.
|
 |
Foster, S. (1991) Valerian. American Botanical Council.
|
 |
Hendriks, R. et al (1981) Pharmacological screening of Valerenal
and some other components of essential oil of Valeriana
officinalis. Planta Medica 42:62.
|
 |
Klich, R. and gladbach, B. (1975) Childhood behavior disorders
and their treatment. Medizinische Welt. 26(25):1251.
|
 |
Lindahl, O. and Lindwall, L. (1989) Double blind study of
a valerian preparation. Pharmacology Biochem. & Behavior.
32:1065.
|
 |
Mowrey, D. (1990) The Scientific Validation of Herbal Medicine.
Cormorant Books.
|
 |
Weiner, M. (1990) Weiner's Herbal. Mill Valley: Quantum
Books.
|
 |
Klotz, V.:Lancet 335:992 (1990).
|
 |
Tyler, V. E.: The Honest Herbal, A Sensible Guide and use
of Herbs and related readings, 3rd edition, (1997), Pharmaceutical
Products Press .
|
 |
Boeters, U. (1969) Treatment of autonomic dysregulation
with valepotriates (Valmane). Pressdizinische Wochenschrift
37:1873.
|
|
| Back
To Index |
|